Pulmagen Therapeutics' Other Investors

Pulmagen Therapeutics raised a round of funding on , . Investors include MVM Life Science Partners.

Pulmagen develops novel and proprietary drugs for chronic respiratory diseases including COPD and asthma. These therapies aim to deliver both improved bronchodilator symptomatic relief and treat the u…

Articles about Pulmagen Therapeutics' Other Investors: